PEG3350 vs Senna After Urogyn Surgery
Polyethylene Glycol 3350 Compared With Senna After Urogynecologic Surgery A Randomized Controlled Trial
St. Joseph's Health, New York
254 participants
Apr 23, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this study is to evaluate whether polyethylene glycol 3350 (PEG3350) versus senna is better at relieving postoperative constipation after urogynecologic surgery. The main questions it aims to answer are: What number of patients taking PEG3350 have obstructed defecation syndrome (ODS), a form of constipation, vs those taking senna in the week after urogynecologic surgery? What patient-level and procedure-level characteristics are associated with postoperative ODS, in patients taking PEG3350 vs senna? participants will: Take their randomized medication daily for seven days after surgery Fill out an ODS questionnaire before and one week after surgery Complete a daily bowel diary for 7 days after surgery
Eligibility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Senna, oral, 8.6mg, 2 tablets daily (up to 4 tablets twice a day) for 7 days
Polyethylene Glycol 3350, oral, 17g, daily for 7 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06825260